“High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report”, RSD, vol. 10, no. 13, p. e93101321104, Oct. 2021, doi: 10.33448/rsd-v10i13.21104.